A detailed history of Signaturefd, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 275 shares of ORIC stock, worth $2,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares
275
Previous 236 16.53%
Holding current value
$2,337
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$7.52 - $11.9 $293 - $464
39 Added 16.53%
275 $2,000
Q2 2024

Jul 29, 2024

SELL
$6.63 - $12.93 $251 - $491
-38 Reduced 13.87%
236 $1,000
Q4 2023

Jan 31, 2024

BUY
$5.41 - $9.43 $1,482 - $2,583
274 New
274 $2,000
Q2 2022

Aug 10, 2022

SELL
$2.7 - $7.07 $59 - $155
-22 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$4.54 - $16.1 $63 - $225
-14 Reduced 38.89%
22 $0
Q4 2021

Jan 25, 2022

SELL
$12.01 - $20.3 $528 - $893
-44 Reduced 55.0%
36 $1,000
Q3 2021

Oct 28, 2021

BUY
$15.9 - $25.22 $1,272 - $2,017
80 New
80 $2,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.